Diana Chavez-Muñoz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Diana Chavez-Muñoz has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alma Ortiz-Plata
Laboratory of Experimental Neuropathology. National Institute of Neurology and Neurosurgery. México City, Mexico
1 shared publication - Citlaltepetl Salinas-Lara
Departamento de Neuropatología, Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez”, Ciudad de Mexico 14269, Mexico
1 shared publication - Daniel Rembao-Bojórquez
Departamento de Neuropatología, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Insurgentes Sur 3877, Tlalpan, Ciudad de México CP 14269, Mexico
1 shared publication Diocelina Navarro-Bastida
1 shared publication- Gilberto Duarte-Medrano
Department of Anesthesia, Hospital Medica Sur, Mexico Puente de Piedra 150, Toriello Guerra, Tlalpan, Mexico City 14050, Mexico
1 shared publication - Juan Luis Gómez-Amador
Department of Neurosurgery, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico
1 shared publication
Latest Publications
- Open Access
- 17 July 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (7) , 384
Pharmacologic Strategies for Intraoperative Hypotension When Ephedrine Is Unavailable: An Evidence-Based Review
Background/Objectives: Intraoperative hypotension (IOHs) affects up to 87% of patients under general anesthesia and is consistently associated with acute kidney injury, myocardial damage, stroke, and mortality. The intermittent unavailability of ephedrine across healthcare systems underscores the need for evidence-based alternatives. This review critically evaluates pharmacological options for IOH when ephedrine is unavailable, focusing on receptor pharmacodynamics, population-specific evidence, and clinical consequences of inadequately managed hypotension. Methods: A narrative, evidence-based review was conducted examining mechanisms of action, dosing strategies, adverse effect profiles, and clinical applicability of key vasoactive agents: ephedrine, phenylephrine, norepinephrine, and epinephrine. Population-specific evidence across obstetric, pediatric, and elderly cohorts was synthesized from randomized controlled trials, meta-analyses, and observational studies. The clinical impact of IOH on neurological, cardiovascular, and renal outcomes was reviewed. Results: Each vasopressor exhibits a distinct receptor-selectivity profile that determines its hemodynamic effect and optimal clinical context. Norepinephrine’s favorable α1/β1 balance tends to preserve cardiac output better than pure α1-agonists and has emerged as a promising alternative in obstetric and elderly populations, although the optimal agent ultimately depends on the underlying mechanism of hypotension and individual patient characteristics. Epinephrine provides combined vasopressor and inotropic support for hypotension with myocardial depression. IOH is associated with a greater than twofold increase in postoperative AKI and significantly elevated risks of myocardial infarction and stroke, with outcomes driven by cumulative hypotensive exposure rather than isolated pressure nadirs. Conclusions: Effective management of IOH requires individualized vasopressor selection guided by underlying pathophysiology, cardiovascular profile, and surgical context. A physiology-based strategy—rather than protocol-driven drug substitution—enables anesthesiologists to achieve precise hemodynamic control and preserve end-organ perfusion even when ephedrine is unavailable.
- 17 July 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (7) , 384
Open AccessPharmacologic Strategies for Intraoperative Hypotension When Ephedrine Is Unavailable: An Evidence-Based Review
Background/Objectives: Intraoperative hypotension (IOHs) affects up to 87% of patients under general anesthesia and is consistently associated with acute kidney injury, myocardial damage, stroke, and mortality. The intermittent unavailability of ephedrine across healthcare systems underscores the need for evidence-based alternatives. This review critically evaluates pharmacological options for IOH when ephedrine is unavailable, focusing on receptor pharmacodynamics, population-specific evidence, and clinical consequences of inadequately managed hypotension. Methods: A narrative, evidence-based review was conducted examining mechanisms of action, dosing strategies, adverse effect profiles, and clinical applicability of key vasoactive agents: ephedrine, phenylephrine, norepinephrine, and epinephrine. Population-specific evidence across obstetric, pediatric, and elderly cohorts was synthesized from randomized controlled trials, meta-analyses, and observational studies. The clinical impact of IOH on neurological, cardiovascular, and renal outcomes was reviewed. Results: Each vasopressor exhibits a distinct receptor-selectivity profile that determines its hemodynamic effect and optimal clinical context. Norepinephrine’s favorable α1/β1 balance tends to preserve cardiac output better than pure α1-agonists and has emerged as a promising alternative in obstetric and elderly populations, although the optimal agent ultimately depends on the underlying mechanism of hypotension and individual patient characteristics. Epinephrine provides combined vasopressor and inotropic support for hypotension with myocardial depression. IOH is associated with a greater than twofold increase in postoperative AKI and significantly elevated risks of myocardial infarction and stroke, with outcomes driven by cumulative hypotensive exposure rather than isolated pressure nadirs. Conclusions: Effective management of IOH requires individualized vasopressor selection guided by underlying pathophysiology, cardiovascular profile, and surgical context. A physiology-based strategy—rather than protocol-driven drug substitution—enables anesthesiologists to achieve precise hemodynamic control and preserve end-organ perfusion even when ephedrine is unavailable.
- Open Access
- 7 January 2025
- Published by IntechOpen
Pituitary Neuroendocrine Tumors and the Role of Their Pattern of Invasion to Adjacent Structures
Pituitary neuroendocrine tumors (PitNets) are considered benign, but can be invasive. They are classified by their size (microadenomas, macroadenomas, and giant adenomas), by their clinical manifestations (functioning, non-functioning), and by the hormonal content detected by immunocytochemistry. PitNets show slow growth, occupying the sellar region and invading adjacent structures. Their size and invasion have been analyzed using different radiological techniques, complemented by surgical observations and pathological findings. We also include the analysis of the frequency and degree of invasion of functioning and non-functioning PitNets in patients at the National Institute of Neurology and Neurosurgery in Mexico City. The analysis of the size and determination of the invasion degree of PitNets, in relation to the clinical presentation characteristics and hormonal content, allows a better understanding of the behavior of these tumors, which is crucial in planning both the surgical strategy and the follow-up, since size is related to the disease evolution.
- 7 January 2025
- Published by IntechOpen
Open AccessPituitary Neuroendocrine Tumors and the Role of Their Pattern of Invasion to Adjacent Structures
Pituitary neuroendocrine tumors (PitNets) are considered benign, but can be invasive. They are classified by their size (microadenomas, macroadenomas, and giant adenomas), by their clinical manifestations (functioning, non-functioning), and by the hormonal content detected by immunocytochemistry. PitNets show slow growth, occupying the sellar region and invading adjacent structures. Their size and invasion have been analyzed using different radiological techniques, complemented by surgical observations and pathological findings. We also include the analysis of the frequency and degree of invasion of functioning and non-functioning PitNets in patients at the National Institute of Neurology and Neurosurgery in Mexico City. The analysis of the size and determination of the invasion degree of PitNets, in relation to the clinical presentation characteristics and hormonal content, allows a better understanding of the behavior of these tumors, which is crucial in planning both the surgical strategy and the follow-up, since size is related to the disease evolution.